title: Gsα activity is reduced in erythrocyte membranes of patients with psedohypoparathyroidism due to epigenetic alterations at the GNAS locus.
abstract: In pseudohypoparathyroidism (PHP), PTH resistance results from impairment of signal transduction of G protein-coupled receptors caused by a deficiency of the Gsα-cAMP signaling cascade due to diminished Gsα activity in maternally imprinted tissues. In PHP-Ia, inactivating mutations of the GNAS gene lead to haploinsufficiency in some tissues with biallelic expression, so in addition to PHP, Albright's hereditary osteodystrophy (AHO) is also present. In PHP-Ib, caused by methylation defects at the GNAS locus, diminished Gsα activity was thought to be limited to maternally imprinted tissues, such as the renal proximal tubule and the thyroid, leading to a lack of AHO. Recently, we demonstrated methylation defects in patients with AHO signs, indicating a connection between epigenetic changes and AHO. Our objective was to determine Gsα activity in erythrocyte membranes in patients with epigenetic defects at the GNAS locus compared to normal controls and patients with inactivating GNAS mutations. Gsα activity and expression, mutation of the GNAS locus, and methylation status were studied in patients with PHP and mild signs of AHO (PHP-Ia: 12; PHP-Ib: 17, of which 8 had some features of AHO). Then, we statistically compared the Gsα activity of the different PHP subtypes. Patients with methylation defects at the GNAS locus show a significant decrease in erythrocyte Gsα activity compared to normal controls (PHP-Ib versus controls, p < .001). This was significantly lower in patients with AHO signs (PHP-Ib + mild-AHO versus PHP-Ib, p < .05). Our research shows that PHP-Ia and PHP-Ib classification is not only overlapped genetically, as reported, but also in terms of Gsα activity. Reduced expression of GNAS due to methylation defects could downregulate Gsα activity in other tissues beyond those described and could also be causative of AHO.
authors.affiliation: Molecular Genetics Laboratory, Research Unit, Hospital Txagorritxu, Vitoria-Gasteiz, Spain.
authors.forename: Celia
authors.initials: C
authors.lastname: Zazo
authors.forename: Susanne
authors.initials: S
authors.lastname: Thiele
authors.forename: Cesar
authors.initials: C
authors.lastname: Martín
authors.forename: Eduardo
authors.initials: E
authors.lastname: Fernandez-Rebollo
authors.forename: Lorea
authors.initials: L
authors.lastname: Martinez-Indart
authors.forename: Ralf
authors.initials: R
authors.lastname: Werner
authors.forename: Intza
authors.initials: I
authors.lastname: Garin
authors.forename: Olaf
authors.initials: O
authors.lastname: Hiort
authors.forename: Guiomar
authors.initials: G
authors.lastname: Perez de Nanclares
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D002864:Chromogranins; D044127:Epigenesis, Genetic; D004910:Erythrocyte Membrane / Q000378:metabolism*; D005260:Female; D019205:GTP-Binding Protein alpha Subunits, Gs / Q000235:genetics*; D056426:Genetic Loci / Q000235:genetics*; D006801:Humans; D015151:Immunoblotting; D007223:Infant; D008297:Male; D009154:Mutation / Q000235:genetics; D011547:Pseudohypoparathyroidism / Q000235:genetics*; D055815:Young Adult
chemical_list: D002864:Chromogranins; C406732:GNAS protein, human; D019205:GTP-Binding Protein alpha Subunits, Gs